Separate names with a comma.
Raising the Bar: A Higher Standard for Mental Health Care This is the latest edition of Forward Focus, a regular feature exploring the future of...
LSD therapy biotech Definium fends off trade-secret lawsuit...
DFTX - Updated Resources and Major Recent Events and Milestones 1. The raise is a major institutional signal, not just “more cash.” Definium...
This hiring slate is bullish as a launch-readiness signal, having like a company that believes DT120 has moved from “clinical asset” to “potential...
Top 3 Health Care Stocks That May Keep You Up At Night In June...
Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity...
Definium’s Phase 3 LSD Win Is Real. The Fracture It Exposed Is Bigger....
Psychedelics iPhone moment [MEDIA]
$PSIL ETF show the three biggest holdings as $DFTX $CMPS $ATAI Others will succeed too, but these three are the unicorns in the psychedelic...
Sekur Private Data Makes First Intl. Call on SekurOne - Launches SekurOne for Android and Web 06/29/2026 - 08:30 AM SekurOne iOS Voice Launch on...
DFTX Russell Reconstitution Update Some people may see the MarketScreener headlines saying Definium Therapeutics was “dropped” from the Russell...
Definium Therapeutics’ Emerge Phase 3 readout looks like a major inflection point for DT120 ODT. The headline is simple: one supervised 100 µg...
Post Phase 3 Results and Raise Clarity I think this week may end up being one of the most important moments the psychedelic medicine sector has...
Definium Therapeutics Announces Positive Topline Results from Phase 3 Emerge Study of DT120 Orally Disintegrating Tablet (ODT) in Major Depressive...
Better Sex, Better Hair, Better Sleep: ‘Humanmaxxing’ Is Here - New York Times...
